Skip to content

Clinical trials

Phase 2/3 HIV Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: HIV Infections Phase: Phase 2/3 Country / region: United States Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20031
20044
20051
20064
20074
20084
20091
20111
20121
20132
20141
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated5
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centers for Disease Control and Prevention6
Gilead Sciences4
National Institute of Allergy and Infectious Diseases (NIAID)3
ViiV Healthcare3
Abbott1
Avexa1
Boehringer Ingelheim1
Johns Hopkins University1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
National Institute on Drug Abuse (NIDA)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
HIV Infections32
Acquired Immunodeficiency Syndrome8
Hepatitis C2
AIDS Dementia Complex1
Cardiovascular Diseases1
Cognitive Dysfunction1
Disease Progression1
Heroin Dependence1
Inflammation1
Lipodystrophy1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.